Jeff Chen, PhD
About Jeff Chen, PhD
Jeff Chen, PhD, serves as the Senior Director of Business Development and Operations in Discovery Research at BridgeBio. He has extensive experience in drug development, managing contract research organizations, and fostering relationships with key opinion leaders in the field.
Current Role at BridgeBio
Jeff Chen serves as the Senior Director of Business Development & Operations in Discovery Research at BridgeBio since 2024. In this role, he manages over 15 contract research organizations (CROs) to achieve drug development objectives. His responsibilities include developing and maintaining relationships with key academic and clinical opinion leaders, as well as presenting program strategies and progress to the C-suite and Board of Directors quarterly.
Previous Experience at BridgeBio
Prior to his current position, Jeff Chen held multiple roles at BridgeBio. He worked as the Director of Business Development & Operations in Discovery Research from 2022 to 2023 and as the Associate Director in the same department from 2021 to 2022. During his tenure, he played a key role in recruiting and building a scientific team that achieved a 100% retention rate, with several team members receiving promotions.
Consulting Experience at ClearView Healthcare Partners
Jeff Chen worked as a Life Sciences Strategy Consultant at ClearView Healthcare Partners from 2020 to 2021. In this role, he provided strategic insights and recommendations for clients in the life sciences sector, leveraging his expertise in drug development and operations.
Educational Background
Jeff Chen earned a Bachelor of Science (B.S.) in Molecular Biology from the Massachusetts Institute of Technology. He furthered his education by obtaining a Doctor of Philosophy (PhD) in Immunology from Yale University. His academic background provides a strong foundation for his work in drug development and research.
Research and Publications
Jeff Chen has published peer-reviewed papers in high-impact journals, accumulating over 2,200 citations. His research contributions have been recognized in publications such as Science, Science Translational Medicine, and Nature. This body of work reflects his deep engagement in scientific research and development.